FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103803877> ?p ?o ?g. }

• W2103803877 endingPage "1205" @default.
• W2103803877 startingPage "1198" @default.
• W2103803877 abstract "Conditionally replicating adenoviruses (CRAds) represent a novel approach for the treatment of cancers resistant to conventional therapies. The efficacy of CRAds might be further improved by using chemotherapeutic agents in a multimodal antitumor approach. We have evaluated the use of Ad5/3-Δ24, a serotype 3 receptor targeted Rb/p16 pathway selective CRAd, in combination with gemcitabine against human ovarian adenocarcinoma. The combination of these agents showed synergistic cell killing in vitro compared to single treatments. However, the effect was dependent on dose and sequencing of the agents. Our results also indicate that gemcitabine reduces the initial rate of Ad5/3-Δ24 replication without affecting the total amount of virus produced. Possible reasons for synergy between Ad5/3-Δ24 and gemcitabine include the chemosensitizing activity of E1A and/or altered replication kinetics. In an orthotopic murine model of peritoneally disseminated ovarian cancer, the combination increased the survival of mice over either agent alone, and almost 60% of treated mice were cured. Sequencing of the agents was critical for toxicity versus efficacy. Mice remained free from intraperitoneal disease, but some succumbed to treatment-related hepatic or bone marrow toxicity. This suggests that improved efficacy may uncover treatment-related toxicity, which needs to be monitored closely in clinical trials." @default.
• W2103803877 created "2016-06-24" @default.
• W2103803877 creator A5014206725 @default.
• W2103803877 creator A5018878912 @default.
• W2103803877 creator A5037710004 @default.
• W2103803877 creator A5042445775 @default.
• W2103803877 creator A5049950699 @default.
• W2103803877 creator A5062078543 @default.
• W2103803877 creator A5067758925 @default.
• W2103803877 creator A5080754209 @default.
• W2103803877 creator A5082137270 @default.
• W2103803877 date "2005-03-31" @default.
• W2103803877 modified "2023-10-12" @default.
• W2103803877 title "Combination of gemcitabine and Ad5/3-Δ24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer" @default.
• W2103803877 cites W1558969188 @default.
• W2103803877 cites W1582164157 @default.
• W2103803877 cites W1973932751 @default.
• W2103803877 cites W1981755236 @default.
• W2103803877 cites W1996591735 @default.
• W2103803877 cites W1999141617 @default.
• W2103803877 cites W2006202262 @default.
• W2103803877 cites W2011206688 @default.
• W2103803877 cites W2019540712 @default.
• W2103803877 cites W2029080338 @default.
• W2103803877 cites W2058680827 @default.
• W2103803877 cites W2077422971 @default.
• W2103803877 cites W2090194056 @default.
• W2103803877 cites W2098521139 @default.
• W2103803877 cites W2108309692 @default.
• W2103803877 cites W2110592777 @default.
• W2103803877 cites W2124127443 @default.
• W2103803877 cites W2141274600 @default.
• W2103803877 cites W2143113338 @default.
• W2103803877 cites W2170329311 @default.
• W2103803877 cites W2313228602 @default.
• W2103803877 doi "https://doi.org/10.1038/sj.gt.3302517" @default.
• W2103803877 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15800658" @default.
• W2103803877 hasPublicationYear "2005" @default.
• W2103803877 type Work @default.
• W2103803877 sameAs 2103803877 @default.
• W2103803877 citedByCount "79" @default.
• W2103803877 countsByYear W21038038772012 @default.
• W2103803877 countsByYear W21038038772013 @default.
• W2103803877 countsByYear W21038038772014 @default.
• W2103803877 countsByYear W21038038772015 @default.
• W2103803877 countsByYear W21038038772016 @default.
• W2103803877 countsByYear W21038038772017 @default.
• W2103803877 countsByYear W21038038772018 @default.
• W2103803877 countsByYear W21038038772019 @default.
• W2103803877 countsByYear W21038038772020 @default.
• W2103803877 countsByYear W21038038772021 @default.
• W2103803877 countsByYear W21038038772022 @default.
• W2103803877 crossrefType "journal-article" @default.
• W2103803877 hasAuthorship W2103803877A5014206725 @default.
• W2103803877 hasAuthorship W2103803877A5018878912 @default.
• W2103803877 hasAuthorship W2103803877A5037710004 @default.
• W2103803877 hasAuthorship W2103803877A5042445775 @default.
• W2103803877 hasAuthorship W2103803877A5049950699 @default.
• W2103803877 hasAuthorship W2103803877A5062078543 @default.
• W2103803877 hasAuthorship W2103803877A5067758925 @default.
• W2103803877 hasAuthorship W2103803877A5080754209 @default.
• W2103803877 hasAuthorship W2103803877A5082137270 @default.
• W2103803877 hasBestOaLocation W21038038771 @default.
• W2103803877 hasConcept C104317684 @default.
• W2103803877 hasConcept C111599444 @default.
• W2103803877 hasConcept C121608353 @default.
• W2103803877 hasConcept C126322002 @default.
• W2103803877 hasConcept C143998085 @default.
• W2103803877 hasConcept C203014093 @default.
• W2103803877 hasConcept C2522874641 @default.
• W2103803877 hasConcept C2776694085 @default.
• W2103803877 hasConcept C2776999253 @default.
• W2103803877 hasConcept C2777844706 @default.
• W2103803877 hasConcept C2780258809 @default.
• W2103803877 hasConcept C2780427987 @default.
• W2103803877 hasConcept C29730261 @default.
• W2103803877 hasConcept C35693153 @default.
• W2103803877 hasConcept C502942594 @default.
• W2103803877 hasConcept C55493867 @default.
• W2103803877 hasConcept C71924100 @default.
• W2103803877 hasConcept C82210918 @default.
• W2103803877 hasConcept C86803240 @default.
• W2103803877 hasConcept C98274493 @default.
• W2103803877 hasConceptScore W2103803877C104317684 @default.
• W2103803877 hasConceptScore W2103803877C111599444 @default.
• W2103803877 hasConceptScore W2103803877C121608353 @default.
• W2103803877 hasConceptScore W2103803877C126322002 @default.
• W2103803877 hasConceptScore W2103803877C143998085 @default.
• W2103803877 hasConceptScore W2103803877C203014093 @default.
• W2103803877 hasConceptScore W2103803877C2522874641 @default.
• W2103803877 hasConceptScore W2103803877C2776694085 @default.
• W2103803877 hasConceptScore W2103803877C2776999253 @default.
• W2103803877 hasConceptScore W2103803877C2777844706 @default.
• W2103803877 hasConceptScore W2103803877C2780258809 @default.
• W2103803877 hasConceptScore W2103803877C2780427987 @default.
• W2103803877 hasConceptScore W2103803877C29730261 @default.
• W2103803877 hasConceptScore W2103803877C35693153 @default.
• W2103803877 hasConceptScore W2103803877C502942594 @default.

• next